What is the Neuroimmunology Market Size?
The global neuroimmunology market was calculated at USD 37.80 billion in 2025 and is estimated to grow from USD 41.15 billion in 2026 to USD 91.88 billion by 2035, registering a CAGR of 8.90% during the forecast period from 2026 to 2035.
Key Takeaways
- North America dominated the global neuroimmunology market with a share of 39% in 2025.
- Asia-Pacific is expected to grow at the fastest CAGR of 13.5% during the forecast period.
- By disease type, the multiple sclerosis segment led the global market with a share of 36% in 2025.
- By disease type, the neuroinflammatory disorders segment held 9% of the market share in 2025 and is expected to grow at the fastest CAGR of 12.5% between 2026 and 2035.
- By treatment type, the monoclonal antibodies segment accounted for a revenue share of 30% in the market in 2025.
- By treatment type, the cell-based therapies segment is expected to grow at the highest CAGR of 18.5% between 2026 and 2035.
Neuroimmunology Market Overview
The neuroimmunology market encompasses the global pharmaceutical, biotechnology, and diagnostic industries focused on understanding, diagnosing, and treating disorders caused by interactions between the nervous and immune systems. The market primarily includes therapies and diagnostic solutions for neuroinflammatory and autoimmune neurological conditions. Growth is largely driven by the increasing prevalence of neurological and autoimmune diseases worldwide, including conditions such as Multiple Sclerosis, Alzheimer’s Disease, and Autoimmune Encephalitis, which continue to increase the demand for advanced treatment and diagnostic options.
